Comparison of the effects of ramipril versus telmisartan in reducing serum levels of high-sensitivity C-reactive protein and oxidized low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus.

@article{Koulouris2005ComparisonOT,
  title={Comparison of the effects of ramipril versus telmisartan in reducing serum levels of high-sensitivity C-reactive protein and oxidized low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus.},
  author={Spyridon N Koulouris and Phivos Symeonides and Konstantinos Triantafyllou and Georgios N Ioannidis and Ilias K Karabinos and Theofanis Katostaras and Mahmud El-Ali and Theodoros Theodoridis and Ekaterini Vratsista and Nikolaos Thalassinos and Vassiliki Kokkinou and Ioannis Nanas and Stamatios F. Stamatelopoulos and Pavlos K. Toutouzas},
  journal={The American journal of cardiology},
  year={2005},
  volume={95 11},
  pages={1386-8}
}
The effect of ramipril (an angiotensin [AT]-converting enzyme inhibitor), telmisartan (an AT-II type 1 receptor blocker), or their combination on inflammation and lipid peroxidation was assessed in 37 patients with type 2 diabetes who were free of coronary artery disease. All regimens were associated with a significant reduction of C-reactive protein and oxidized low-density lipoprotein cholesterol serum levels (p <0.001). These results further enlighten the mechanisms underlying the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Similar Papers

Loading similar papers…